Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.

They do look quite different to seborrheic keratosis, but it may be worth having a little look online at neurofibroma images to check that that’s not what you’ve got. TIP: The NHS has warned ...

The National Consumer Disputes Redressal Commission (NCDRC) has directed a Kolkata-based vascular surgeon and Nightingale ...

Ouardi, K. , Hamama, J. , Harbili, M. , Ouraini, S. , Benariba, F. and Errami, N. (2025) Silent Growth: 18-Year History of an Upper Lip Schwannoma. Voice of the Publisher, 11, 128-135. doi: 10.4236/vp ...

Neurofibrosarcoma is also known by several other names, such as: Malignant schwannoma Malignant neurofibroma Malignant neurilemmoma Malignant mesenchymoma of nerve sheath origin Neurogenic ...

In a mouse model of NF1, oral dosing of mirdametinib inhibited ERK phosphorylation and reduced neurofibroma tumor volume and proliferation. <2yrs (BSA <0.40m 2): not established. Take with or ...

Positive updates continue to emerge from Nicklaus Children's Hospital in Miami, where young Damir Ortiz, a Cuban child in ...

Young Damir Ortiz Ramírez from Cuba, diagnosed with neurofibromatosis type 1, a plexiform neurofibroma in his right eye, and ...

A single neurofibroma may not be indicative of this disorder, but multiple tumors are strongly suggestive of NF1.